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Abstract  The theme for this keynote presentation is 
one of change; it recognises the paradigm shift from treating 
„illness‟ to promoting „wellness‟ while at the same time 
reporting the need for a multidisciplinary multiscale systems 
approach to the representation of physiological attributes 
and behaviour. Embryonic development of the cardiac cush-
ions that eventually become the heart valve flaps is used as a 
case study to illustrate the utility of the multiscale systems 
engineering approach. 
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1.  INTRODUCTION 
 
Measurement in medicine and biology can be typi-
fied by physiological measurement of chosen vari-
ables that describe or explain underlying normal or 
pathological phenomena. One is then able to treat an 
illness based on this evidence, taken together with 
other clinical signs and symptoms, family history and 
the like. Traditional measurements include a determi-
nation of signal trends (e.g. electrocardiogram, elec-
troencephalogram), physical flows (e.g. blood flow in 
a coronary artery), rates (e.g. heart rate, respiratory 
rates), physical pressures (e.g. arterial blood pressure), 
inputs and outputs (e.g. fluid balance), and concentra-
tions (e.g. metabolites). Then there are the derived 
measurements and scores – such as heart rate variabil-
ity and Glasgow Coma Score that provide summary 
information by combining data in a standard way. 
These physical measurements are supplemented by 
data and information that stem from imaging tech-
nologies. Trends in the uptake of integrated measure-
ment systems to solve real world clinical problems 
using different combinations of these data can be 
detected. Rising costs of healthcare is acting as a 
driver for both organisational change and an increased 
rate of the adoption of technological change. There is 
a clear attempt by clinical managers to reduce the 
„length of stay‟ in expensive hospital settings by in-
creasing the burden on care in the community where 
the patient remains at home for treatment and recov-
ery. There remains a need for home-based healthcare 
to provide physiological measurement for data moni-
toring as well as provide a means to transmit these 
data to clinics for patient assessments. Technical solu-
tions involved in this change include telecare and 
telehealth technologies, able to collect and transmit 
data using robust, easy to use devices. Other techno-
logical advances along the same axis include „wear-
able‟ data collection devices, where perhaps sensors 
are sewn into the material of vests or shirts/blouses. A 
correctly positioned accelerometer will provide infor-
mation on whether a patient is upright or supine, and 
can therefore detect falls in the home. Use of an RFID 
placed in the inner sole of a shoe can provide location 
information for (say) patients with dementia. A smart 
phone with in-built GPS can provide a similar solu-
tion. 
A second axis of change is associated with a 
change in mind set of what health systems are for and 
how they can be used. Again there are clear signals 
from the funding agencies who support research that 
advances are needed in disease prevention and health 
promotion. The agenda has changed from just treating 
„illness‟ to include promoting „wellness‟. Here, the 
same home-based monitoring devices that allow pa-
tients to leave hospital earlier than before can be used 
to monitor continued well-being.    
Though the work summarised above is clearly im-
portant and provides both impact and value to clinical 
decision-making, the focus of this paper is on a para-
digm shift in medicine and biology brought on by 
technological advances and the measurement science 
that underpin them. It is widely anticipated that the 
21
st
 Century will be the biologist‟s century to excel, 
just as the physicists did in the last century. The bi-
ologist‟s century started well, with the sequencing of 
the human genome in 2001 – a process which means 
that all genes and proteins that they encode for are 
known and have been catalogued. These data and 
information are generally available, though their con-
tent may be distributed in databases in various loca-
tions around the globe. Although researchers are be-
ginning to identify genotype to phenotype interac-
tions, one might argue fairly successfully that the full 
extent of using the human genome sequence remains 
yet to be fully explored and exploited. Hence the 
paradigm shift; as discussed above there is already a 
perceptible move from „treating illnesses‟ to „preven-
tion of disease‟ and „wellness‟. Here, it is anticipated 
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that molecular medicine will have a huge impact. 
Costs involved in sequencing the genome have spi-
ralled ever downwards whereas at the same time the 
number of active sites on chromosomes that have been 
associated with a particular phenotype have increased. 
It is likely to become common practice for individuals 
to have a copy of their own genome sequence, able to 
be used for what is termed „personalised medicine‟.   
 
2. MULTISCALE SYSTEMS ENGINEERING 
 
Multiscale systems engineering can be defined as a 
group of methods, tools and techniques used to solve 
physical problems that have important features in 
multiple spatial and/or time scales. To take advantage 
of personalised medicine requires a link between the 
genome and the diasporas of cells and tissue types that 
represent the end of the signalling chain. In fact, there 
are recognised levels of scale in both the spatial and 
time domain that represent the intermediary stages of 
phenotype development. For instance, in the spatial 
scale there is the protein level (10
-9 
m), the cell level 
(10
-6 
m), the tissue level (10
-3 
m), and the organ level 
(10
0 
m). The tools and techniques used to understand 
the physiological phenomena vary according to the 
level of scale, but include mathematical modelling 
using ordinary and partial differential equations, sto-
chastic models, and pathway (network) models. In the 
absence of a specific multiscale modelling program-
ming language, scale linking (that is the method by 
which models of different scales are integrated), is 
achieved currently by linking the ontological informa-
tion that underpins and relates the terms used to each 
other.  
Though multiscale systems engineering is being 
applied to all human organs through a worldwide 
research initiative known as the Physiome project, 
which is being co-ordinated by Peter Hunter and his 
group at Auckland University [1], the dynamics of 
cardiac function are attracting a lot of attention. By far 
the majority of the work is investigating the normal 
and diseased adult heart. In contrast, the research 
group at Loughborough University, together with 
research partners in Rennes and Paris, is one of only a 
few centres that is looking at the heart as it develops 
in the womb [2]. Specifically, the international team is 
attempting to further understand the multiscale proc-
esses that give rise to a congenital heart defect known 
as the tetralogy of Fallot (ToF). One of the four signs 
that define this condition is a septal defect in the wall 
that separates the right and left ventricle. The septum 
itself is formed as a result of epithelial to mesenchy-
mal transition (EMT), and it is this process that we 
first wish to understand from a multiscale perspective.  
 
3.  CASE STUDY 
 
3.1 Anatomic Level 
Cardiac development commences in week 2 (em-
bryonic day 14 - E14) of gestation and is fully formed 
by week 8. It is in week 2 that the first cardiac mile-
stone is achieved. Though the primitive heart is in the 
shape of a tube at this stage, the cardiac muscle is 
developed sufficiently for muscle contractions to oc-
cur, and as a consequence blood flow through the 
cardiac tube. This activity can be measured via elec-
trophysiological recording of the primitive heart beat 
[3]. The walls of the heart tube comprise three layers: 
endocardium; „cardiac jelly‟; and an outer layer of 
myocardium. At specific sites in the heart tube on 
around E26, the cells of the endocardium start to take 
on a mesenchymal phenotype and at the same time 
invade the middle cardiac jelly layer of the heart tube 
wall. This causes localised swellings termed „endo-
cardial cushions‟ which are the precursors of heart 
valves and the inner wall structures of the heart. E26 
is also a milestone in anatomic structure of the devel-
oping heart as two simultaneous processes termed 
„looping‟ and „wedging‟ take place, allowing the final 
structure of the heart to be realised by about E32.  
E26 to E32 is a crucial time in the development of 
the embryonic heart, as congenital birth defects due to 
abnormal looping and wedging become apparent at 
this time.  
 
3.2 Cellular Level 
The endocardial cushions mentioned above play a 
crucial role in the formation of the inner structures of 
the heart – the heart valves, the septa and the trabecu-
lar musculature of the left ventricle. EMT is the un-
derpinning cellular process, so it follows that abnor-
mal EMT leads to (typically) a septal defect (more 
commonly known as a „hole in the heart‟). EMT oc-
curs because endothelial cells lose their adhesion to 
each other. This process has been simulated using a 
Cellular-Potts model that demonstrates different sce-
narios depending on level of adhesion. Results show a 
good similarity in behaviours between the in silico and 
in vitro models. 
 
3.3 Protein Level 
Several signalling pathways have been identified 
as important in EMT. To continue the argument being 
developed for endothelial cell adhesion to be a central 
player in normal heart development, the notch family 
of proteins also play an important role. In the endo-
cardium notch 1 is expressed in cushion forming re-
gions, but not expressed in other regions; whereas it is 
the other way around in the myocardium. Notch also 
activates genetic transcription of the snail family of 
proteins, which in turn inhibit transcription of the 
protein VE-Cadherin. It is this latter protein that aids 
cell adhesion. Thus an activated notch protein signal-
ling network induces a loss of cohesion. Mutations in 
genes that encode the notch signalling proteins can 
therefore lead to congenital heart disease. In particu-
lar, mutations in JAG1 (a ligand for notch receptor 
proteins) are associated with tetralogy of Fallot. 
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3.4 Genome level 
A hypothesis put forward by Bajolle [4] suggests 
that a heart defect may originate from different em-
bryological mechanisms including a formation ab-
normality of the endocardial cushions. The complexity 
of the multiscale representation increases, as these 
mechanisms are controlled by multiple genes (e.g. 
Pax3, Pitx2, Tbx1, Fgf8, Bmp). The result is a concept 
known as „one heart disease – several mechanisms – 
several genes‟. As there is redundancy in the gene 
regulatory networks that control heart development, 
mutations in several different genes acting through 
many mechanisms can lead to the same disease pheno-
type. Equally, a disease phenotype might be caused by 
one of several different mutations, as more than one 
gene controls each developmental mechanism. 
 
4. DISCUSSION 
 
The paper has considered advances in measure-
ment in medicine and biology. While important 
strands of work have been alluded to that refer to the 
use of telemedicine and wearable systems to drive 
down the anticipated costs of healthcare, the case 
study introduced a new method that investigates a 
system from a holistic stance. Multiscale systems 
engineering is not restricted to biomedical applica-
tions, as the approach is starting to be used in chemi-
cal engineering and materials science. In both of these 
cases, the work tends to be industry led, as they see a 
way to make improvements in processes that may 
develop into unique selling points for competitive 
advantage. The case study has shown the utility of the 
multiscale systems engineering approach with an 
application in human embryology and physiology. 
However, no matter what the application domain, 
issues remain. These issues include the development 
of novel data collection methods that are applicable 
across all spatial scales simultaneously; the same 
issues arise for representing the data and information 
in a way that allows for efficient and effective integra-
tion. In recent years there has been a lot of work on 
visualisation of data, the multiscale approach is a good 
test of these methods, where simultaneously occurring 
events might be evident across spatial scales, but 
might have different dynamics across the time scales. 
In in silico simulations multiscale model validation 
requires new methods that are as yet not in the public 
domain. In fact whereas there is a catalogue of meth-
ods, tools and techniques to attack problems at one 
level of scale, there are very few in the public domain 
that are truly applicable to multiscale problems. This 
leads to a further issue termed „scale linking‟, or the 
ability to connect models together to demonstrate 
behaviour at more than one scale simultaneously. One 
method available currently is to convert the models 
used at adjacent spatial scales into a meta-computer 
language that essentially acts in a way to integrate 
structure and function. However, the Project Fallot 
team have used an alternative approach, that of ontol-
ogy-driven development to achieve the same end. 
Here, the team has taken advantage of the fact that 
clinical terms that are used in descriptions of entities 
at different scales occur in more than one ontology 
that overlap each other. This may be seen as a „work 
around‟ rather than a fundamental solution but there is 
an option for further work in developing an integrated 
information system based on in turn information ar-
chitectures, information models, and information 
configurations. 
 
5. CONCLUSION 
 
A multiscale systems engineering approach has 
been adopted to investigate a complex adaptive sys-
tem characterised by identified and known failure 
modes in terms of congenital heart disease. It is clear 
that much work remains, not just on the application, 
but also on the methods and tools available to tackle 
multiscale investigations. One promising way forward 
might be to transfer knowledge gained in and between 
domains with each other. For instance, there is an 
opportunity for the Project Fallot team to apply their 
approach to problems in materials science and aero-
nautical engineering. It remains to be seen if the ap-
proach has the capability to solve problems from other 
domains. 
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